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All-trans Retinoic Acid-Induced Hyaluronan
Production and Hyperplasia Are Partly Mediated by
EGFR Signaling in Epidermal Keratinocytes
Sanna M. Pasonen-Seppa¨nen1, Edward V. Maytin2, Kari J. To¨rro¨nen1, Juha M.T. Hyttinen1, Vincent C. Hascall2,
Donald K. MacCallum3,4, Anne H. Kultti1, Tiina A. Jokela1, Markku I. Tammi1 and Raija H. Tammi1
All-trans retinoic acid (RA) compromises epidermal differentiation and causes keratinocyte hyperproliferation
through mechanisms not completely understood, but may involve the regulatory matrix molecule hyaluronan.
In this work, the influences of all-trans RA on epidermal morphology and hyaluronan metabolism were
examined in organotypic and monolayer cultures of rat epidermal keratinocytes (REKs). All-trans RA treatment
of organotypic REK cultures (10 days) increased the synthesis of hyaluronan, the expression of hyaluronan
synthases Has2 and Has3, and the CD44 receptor, with hyperplasia of the epidermis. The hyperplasia and
hyaluronan production induced by all-trans RA were blocked with (1) AG1478, an inhibitor of the EGFR; (2)
UO126, an inhibitor of the MAPK/ERK kinase, and (3) GM6001, an inhibitor of the matrix metalloproteinases.
These effects were consistent with the findings that all-trans RA upregulated heparin-binding epidermal growth
factor-like growth factor mRNA expression and increased the phosphorylation of EGFR and extracellular signal-
regulated kinase 1/2 (ERK1/2). Interestingly, the activation of EGFR and ERK1/2 was seen already 30minutes after
all-trans RA treatment, suggesting that the activation of this signaling pathway is a primary response to all-trans
RA. These results indicate that the effects of all-trans RA on keratinocyte proliferation and hyaluronan synthesis
are partly mediated through EGFR signaling.
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INTRODUCTION
Hyaluronan is a high molecular mass glycosaminoglycan
synthesized at the inner surface of the plasma membrane by
hyaluronan synthases (HAS1, HAS2, HAS3) and composed of
alternating D-glucuronic acid and N-acetyl-D-glucosamine
residues (Weigel et al., 1997). This glycosaminoglycan is a
key component of vertebrate extracellular matrix and is
involved in a wide range of cellular functions such as
adhesion, proliferation, migration, and differentiation through
its unique physicochemical properties and interactions with
specific cell surface receptors (Tammi et al., 2002). Hyalur-
onan is the main extracellular matrix molecule in skin
epidermis, and is actively synthesized by epidermal basal and
spinous cells (Tammi and Tammi, 1991; Akiyama et al.,
1994). We have previously shown that factors that stimulate
keratinocyte proliferation and migration, such as EGF and
keratinocyte growth factor, also stimulate keratinocyte
hyaluronan production by upregulating Has2 and Has3
(Karvinen et al., 2003; Pasonen-Seppa¨nen et al., 2003),
whereas factors that arrest keratinocyte growth and stimulate
differentiation, such as hydrocortisone and transforming
growth factor-b (TGF-b), downregulate hyaluronan synthesis
(A˚gren et al., 1995; Pasonen-Seppa¨nen et al., 2003). This
suggests that hyaluronan has an important role in the
proliferative reactions of the epidermis and that it is also
involved in keratinocyte differentiation.
Vitamin A and its derivatives (retinoids) are important
regulators of keratinocyte proliferation and differentiation.
The effects of retinoid treatment vary between different cells
and depend on the physiologic state of the host tissue at the
time of treatment. In normal human skin, all-trans retinoic
acid (RA) stimulates keratinocyte proliferation, leading to
thickening of the epidermis (Fisher and Voorhees, 1996).
All-trans RA is thought to exert its molecular actions
through nuclear receptors, the retinoic acid receptors (RARa,
b, g), and the retinoidXreceptors (RXRa, b, g). RXRa–RARg
heterodimers are the main functional units mediating
RA-induced effects in epidermal keratinocytes through
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binding to retinoic acid-response elements (RAREs) of the
target genes (Fisher and Voorhees, 1996). Upon retinoid
binding, the receptors stimulate or antagonize the activation
of target genes by interacting with coactivators and recruiting
the transcriptional machinery (reviewed in Xiao et al., 1999;
Bastien and Rochette-Egly, 2004). Recently, Has2 was found to
be a primary all-trans RA responding gene with a functional
RARE cluster between 1,207 and 1,236 bp upstream of the
transcriptional start site (Saavalainen et al., 2005).
In addition to the direct effects on gene expression via its
nuclear receptors, recent studies have shown that RA-induced
epidermal hyperplasia is mediated by the heparin-binding
epidermal growth factor-like growth factor (HB-EGF) (Varani
et al., 2001; Chapellier et al., 2002; Yoshimura et al., 2003;
Kimura et al., 2005; Rittie et al., 2006). HB-EGF belongs to the
EGF family (Higashiyama et al., 1991), which comprises several
mitogenic members. Pro-HB-EGF, like most EGF family
members, is synthesized as a membrane-anchored protein that
must be proteolytically processed to become fully active
(Fischer et al., 2003). Matrix metalloproteases (MMPs) 2, 3, 7,
and 9, as well as members of the disintegrin and metallopro-
tease family (ADAM 9, 10, 12, and 17), have been reported to
be responsible for pro-HB-EGF activation (Roelle et al., 2003;
Nanba and Higashiyama, 2004; Blobel, 2005). This ectodomain
shedding has been recognized as one of the key events during
epidermal cell activation. HB-EGF acts as an autocrine–par-
acrine–juxtacrine ligand for the EGFR (ErbB1), which results in
the activation of the MAPK-signaling pathway (Iwamoto and
Mekada, 2000). All-trans RA has been shown to regulate this
critical signaling pathway in various cell types (Yen et al., 1999;
Crowe et al., 2003; Canon et al., 2004; Rittie et al., 2006).
All-trans RA stimulates hyaluronan production in porcine
epidermis (King, 1984), hairless mouse skin (Margelin et al.,
1996), human skin organ cultures (Tammi and Tammi, 1986), and
human keratinocyte cultures (Akiyama et al., 1994). However, the
mechanism of this stimulation is not completely known. A part of
the stimulation in epidermal keratinocytes is directly through
upregulation of Has2 expression by activated RAR-RXR receptors
(Saavalainen et al., 2005), but additional ways of stimulation may
operate via induced HB-EGF expression, or through dermal
components, or through novel nongenomic ways.
This study explores the effects of all-trans RA on epidermal
hyaluronan metabolism and morphology in keratinocyte
cultures. Organotypic rat epidermal keratinocyte (REK)
cultures allowed us to study the effects of all-trans RA on
differentiating keratinocytes without the influence of dermal
cells. The results demonstrate that all-trans RA is able to
activate the EGFR-signaling pathway directly, without de
novo protein synthesis, and induces upregulation of Has2,
Has3, and HB-EGF mRNA leading to the elevated hyaluronan
production and epidermal hyperplasia.
RESULTS
Hyaluronan accumulation and epidermal hyperplasia induced
by all-trans RA are counteracted by inhibitors of metalloproteinases,
EGFR, and MEK in organotypic keratinocyte cultures
REKs cultured for 2 weeks on collagen gel form a
morphologically normal epidermal tissue, consisting of 3–4
vital cell layers and a well-organized stratum corneum
(Figure 1a and b; Pasonen-Seppa¨nen et al., 2001). When
all-trans RA was added at 0.1 mM concentration, the thickness
of the vital part of the epidermis was increased considerably
(Figure 1c, d, and k). All-trans RA markedly increased
hyaluronan staining intensity in REK cultures. In addition to
the accumulation of hyaluronan in all vital cell layers of the
epidermis, all-trans RA also increased hyaluronan content in
the underlying collagen matrix (Figure 1c). Immunostaining
for CD44 revealed an increased signal intensity, with more
positive cell layers in all-trans RA-treated cultures than in
control cultures (Figure 1d).
Epidermal hyperplasia induced by all-trans RA was
reversed by the EGFR inhibitor AG1478 (Figure 1e, f, and
k) and by the MAPK/ERK kinase (MEK) inhibitor UO126
(Figure 1g, h, and k). GM6001, a broad-spectrum inhibitor
of matrix metalloproteinases (MMPs), totally blocked all-trans
RA-induced epidermal hyperplasia and produced a thin,
almost atrophic epidermis (Figure 1i–k). All of these inhibitors
also reduced the all-trans RA-induced hyaluronan staining
intensity (Figure 1e, g, and i). All inhibitors also reversed
the effect of all-trans RA on CD44 staining intensity
(Figure 1f, h, and j).
All-trans RA stimulates while inhibitors along the EGFR-
signaling pathway reduce hyaluronan synthesis in REK
organotypic cultures
The total hyaluronan concentration of REK organotypic
cultures (comprising hyaluronan in epidermis, collagen
matrix, and medium) at 2 weeks was approximately
2 mg mg1 tissue dry weight, as measured by enzyme-linked
sorbent assay (ELSA). The EGFR kinase inhibitor AG1478
caused a 35% decrease in this basal hyaluronan concentra-
tion. While with the MEK inhibitor (UO126) and the MMP
inhibitor (GM6001) (Figure 2a), the basal hyaluronan synthe-
sis was reduced approximately 50%, suggesting that either
endogenous growth factors or those in the supplemented
medium stimulate hyaluronan production via EGFR-signaling
pathway. All-trans RA raised the total hyaluronan concentra-
tion by 50% (Figure 2a). This RA-induced increase in
hyaluronan concentration was partially reversed by the
EGFR inhibitor (AG1478), whereas the MEK kinase
inhibitor (UO126) and the MMP inhibitor (GM6001)
totally blocked the stimulatory effect of all-trans RA,
bringing the concentration well below the control level
(Figure 2a).
The experiments suggested that endogenous EGFR ligands
and all-trans RA might activate EGFR in organotypic REK
cultures and thereby regulate hyaluronan synthesis (Figure
2a). The effects of all-trans RA and the inhibitors on
hyaluronan synthesis were confirmed to operate in mono-
layer REK cultures also (Supplementary Data 1). After
24 hours treatment, all-trans RA doubled the concentration
of hyaluronan in the growth medium, and this increase was
inhibited by the EGFR inhibitor (AG1478), the MEK inhibitor
(UO126), and the MMP inhibitor (GM6001) (Supplementary
Data 1), results similar to those in the organotypic cultures
(Figure 2a). In contrast to the results in organotypic cultures,
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the EGFR inhibitor alone (without all-trans RA) did not exert
any effect on the basal hyaluronan synthesis in monolayer
cultures, suggesting that autocrine/paracrine EGFR signaling
was less involved in the monolayer cultures.
Molecular mass distributions of metabolically labeled
hyaluronan in the media were analyzed using Sephacryl
S-1000 gel chromatography. Relatively high proportions of
the newly synthesized hyaluronan in the organotypic cultures
were of high molecular mass (B5106 kDa). Neither
all-trans RA nor the EGFR inhibitor changed the relative
molecular mass distribution of secreted hyaluronan
(Figure 2b), suggesting that all-trans RA did not affect the
extracellular breakdown of hyaluronan.
Metabolic labeling provided a direct measure of the
synthesis of hyaluronan, and also allowed a simultaneous
determination of newly synthesized sulfated glycosamino-
glycans. During 24 hours labeling, all-trans RA (0.1 mM)
stimulated the synthesis of all glycosaminoglycans in REK
organotypic cultures. The effect on hyaluronan synthesis
(Figure 2c) was more pronounced (2.5-fold) as compared to
the 1.7-fold increase in chondroitin sulfate (Figure 2d) and
heparan sulfate (Figure 2e). Especially the amount of
hyaluronan released into the matrix (collagen and medium)
was increased by all-trans RA. The inhibitors of EGFR
signaling, MEK signaling, and MMP activity all blocked the
stimulation of the synthesis of hyaluronan and sulfated
glycosaminoglycans, induced by all-trans RA (Figure 2c–e).
All-trans RA upregulates Has2 and Has3 expression
RNA was isolated from 2-week-old REK organotypic cultures
treated for 4 hours with all-trans RA with or without the EGFR
inhibitor, and subjected to RT-PCR. The expression level of
Has1 was very low, and no changes related to all-trans RA-
treatment were detected (data not shown). Screening of
mRNA levels at different time points following the introduc-
tion of all-trans RA suggested that Has2 and Has3 (Figure 3a)
were rapidly elevated in all-trans RA-treated cultures. The
induction of Has2 was confirmed with real-time RT-PCR after
4 hours treatment with all-trans RA (Figure 3b). There was
also a trend for the activation of Has3. Inhibition of EGFR,
MEK, and MMPs prevented the all-trans RA-induced expres-
sion of Has2 and Has3 (Figure 3b). All-trans RA had only a
minor effect on CD44 mRNA expression.
Neutralizing anti-HB-EGF counteracts the effects of all-trans RA
on keratinocyte hyaluronan production
Because it has been shown that all-trans RA induces HB-EGF
expression in differentiated keratinocytes (Varani et al.,
2001), and our data suggested that EGFR signaling was
involved in RA-induced hyaluronan synthesis (Figure 2), we
screened HB-EGF mRNA levels at different time points
following the introduction of all-trans RA using RT-PCR. It
showed that HB-EGF mRNA was elevated rapidly (in 1 hour)
in all-trans RA-treated cultures (data not shown). Quantitative
real-time RT-PCR showed a 3.5-fold increase in HB-EGF
mRNA after 4 hours treatment with all-trans RA (Figure 3b).
Inhibitors of EGFR, MEK, and MMP inhibited this induction
(Figure 3b).
The involvement of HB-EGF in all-trans RA induction was
also investigated by adding a neutralizing antibody to HB-
EGF (4 mg ml1) into the organotypic REK cultures treated for
10 days with all-trans RA (0.1 mM). It appeared that the
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Figure 1. Hyaluronan and CD44 distribution in organotypic REK cultures.
Two-week-old organotypic cultures were fixed, processed for histology, and
stained for hyaluronan and CD44 as described in Materials and Methods.
(a, b) Controls were treated with the DMSO vehicle. (c, d) All-trans RA
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neutralizing antibody caused a marked decrease in the all-
trans RA-induced hyaluronan production (Figure 4a).
A similar result was also seen in monolayer cultures
(Supplementary Data 1). The data suggest that the upregula-
tion of HB-EGF expression after all-trans RA stimulation
increased keratinocyte hyaluronan production. Furthermore,
the neutralizing anti-HB-EGF reduced the all-trans RA-
induced epidermal hyperplasia (Figure 4b).
All-trans RA activates EGFR and ERK1/2
To support the hypothesis that all-trans RA regulates
keratinocyte proliferation and hyaluronan production via
EGFR signaling, we studied the phosphorylation of this
receptor and its downstream targets after 30 minutes to
12 hours of all-trans RA stimulation. Treatment of organotypic
REK cultures for 30 minutes with all-trans RA caused a rapid
upregulation of EGFR and extracellular signal-regulated
kinase 1/2 (ERK1/2) phosphorylation (Figure 5a). The
EGFR inhibitor AG1478 blocked the EGFR and ERK1/2
activation induced by all-trans RA. The MMP inhibitor
GM6001 had a similar but not so prominent effect on
EGFR and ERK1/2 phosphorylation. The MEK inhibitor
UO126 reversed the effect of all-trans RA on ERK1/2
activation, but had no influence on EGFR, an upstream
effector of the signaling pathway. These data support the
hypothesis that the stimulatory effect of all-trans RA on
keratinocyte proliferation and hyaluronan synthesis is
mediated by EGFR.
The response in ERK1/2 phosphorylation after all-trans RA
treatment was evident in 30 minutes (Figure 5a) and lasted at
least for 12 hours (data not shown). All-trans RA also elevated
the phosphorylation level of c-Jun N-terminal kinase and the
transcription factors STAT3 and c-Jun after 4 hours treatment
(Figure 5c). This activation may be due to the secondary
effects of all-trans RA, because increased phosphorylation of
c-Jun N-terminal kinase, STAT3, and c-Jun was not found
after 30 minutes or 2 hours (data not shown) treatments with
all-trans RA. Neither all-trans RA nor AG1478 significantly
influenced the phosphorylation of PI3K and Elk (Figure 5c).
Protein synthesis inhibition by cycloheximide (10 mg ml1)
did not block ERK1/2 activation after all-trans RA stimulation
(at 4 hours) (Figure 5d). This confirms the idea that all-trans
RA is able to activate EGFR-signaling pathway directly
without de novo protein synthesis.
All-trans RA suppresses epidermal differentiation
Keratin 10 immunostaining, an indicator of epidermal
differentiation, was reduced in all-trans RA-treated organo-
typic REK cultures (Figure 6a). The reduced expression of
keratin 10 and the inhibition of profilaggrin processing
caused by all-trans RA were also confirmed with western
blotting (Figure 6c). Interestingly, the inhibitors that blocked
the effects of all-trans RA on hyaluronan production and
proliferation (EGFR inhibitor, MEK inhibitor, and MMP
inhibitor) were not able to reverse the effects of all-trans RA
on either keratin 10 expression (data not shown) or
profilaggrin maturation (Figure 6c), and only one of them,
the MEK inhibitor (UO126), partially reversed RA’s effect
on keratin 10 expression (data not shown). This suggests that
all-trans RA influences keratinocyte differentiation through
signaling pathways different from those governing hyal-
uronan synthesis and epidermal hyperplasia.
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DISCUSSION
This study indicates that the epidermal hyperplasia caused by
all-trans RA is associated with the activation of the EGFR-
signaling pathway, hyaluronan accumulation, and increased
CD44 in rat keratinocyte cultures. Enhanced hyaluronan
production in all-trans RA-treated organotypic cultures was
due to upregulation of Has2 and Has3, a finding in line with
previous experiments in human keratinocytes (Sayo et al.,
2004; Saavalainen et al., 2005). Furthermore, the present
findings with all-trans RA confirm our previous findings
concerning the close correlation of epidermal hyaluronan
production with keratinocyte proliferation and the inverse
correlation with differentiation (A˚gren et al., 1995; Karvinen
et al., 2003; Pasonen-Seppa¨nen et al., 2003).
The effects of all-trans RA on proliferation, differentiation,
and hyaluronan synthesis, similar in the epidermis in vivo
(data not shown) and the organotypic epidermal keratinocyte
cultures, indicate that these effects of all-trans RA are targeted
directly to epidermal keratinocytes, without the contribution
of dermal cells or signals (Varani et al., 1993, 1994). The fact
that the stimulation in hyaluronan production was also
evident in monolayer cultures suggests that the signaling
systems for all-trans RA-mediated hyaluronan upregulation
are operating both in differentiating keratinocytes and in
monolayers resembling the basal cell phenotype.
Although retinoids have been used in several skin diseases
like psoriasis and acne, their exact therapeutic mechanisms,
such as regulation of keratinocyte growth, are largely
unknown. Retinoids are generally expected to exert their
primary action through gene expression by binding and
activating retinoid receptors (RARs and RXRs). These ligand-
activated transcription factors control target gene expression
by interacting with consensus sequences (RAREs) in the
promoter regions of genes (Bastien and Rochette-Egly, 2004).
However, in keratinocytes only a few primary all-trans RA
responding genes with functional RAREs have been found
(Xiao et al., 1999). Recently, human Has2 was found to have
a functional RARE and to be one of the all-trans RA inducible
genes in keratinocytes (Saavalainen et al., 2005), which is in
accordance with the elevated Has2 expression we found in
rat keratinocytes after all-trans RA exposure. However, rat
Has2 promoter sequences have marked differences com-
pared with those in the human Has2. Therefore, the control
mechanisms may be different although all-trans RA increases
Has expression in rat and human keratinocytes. It is
noteworthy that retinoids are also known to control genes
that do not contain classical RARE motifs, which means that
these genes are regulated via secondary events or alterna-
tively, all-trans RA-RAR complexes are able to activate
intracellular signaling molecules or transcription factors
directly. Such alternative signals for gene activation may be
mediated by NF-kB (Dai et al., 2004) and direct binding of
all-trans RA–RAR complexes to components of the ERK-
signaling pathway (Canon et al., 2004). The rapid activation
we found in EGFR and downstream signaling proteins, such
as ERK1/2, is compatible with these non-classical routes of
all-trans RA signaling.
The hyperplastic response to all-trans RA in the epidermis
has been connected to HB-EGF expression (Xiao et al., 1999;
250
Control
AG1478
RA+AG
RA
150
200
100
50
Has2
Has2
Has3
Has3 HB-EGF CD44
0
4 Control
All-trans RA
All-trans RA+AG1478
All-trans RA+UO126
All-trans RA+GM6001
* *
* *3
2
1R
el
at
ive
 m
R
N
A 
ex
pr
es
sio
n
0
3.5
2.5
1.5
0.5
0 1 2 3 4 6 8 0 1
Time (hours)
2 3 4 6 8
250
150
200
100
50
0
m
R
N
A/
G
AP
DH
 (%
 of
 co
ntr
ol)
Figure 3. The expression of Has2, Has3, HB-EGF, and CD44. Organotypic
REK cultures were treated with all-trans RA with or without the inhibitors
(AG1478, UO126, and GM6001) for 1–8 hours, total RNA was isolated and
reverse transcribed, and analyzed by (a) semi-quantitative RT-PCR (1–8 hours
treatment) and (b) real-time PCR (4 hours treatment). The results are shown as
means7SEM of three separate experiments (a).*Po0.05, one-way analysis of
variance, Tukey’s post hoc test.
Control
All-trans RA
All-trans RA +
anti-HB-EGF (AF)Hy
a
lu
ro
na
n 
(%
 of
 co
ntr
ol)
150
50
0 Control RA RA+
AF
AF
100
Figure 4. The effects of neutralizing anti-HB-EGF on hyaluronan production
and epidermal hyperplasia. (a, b) Organotypic cultures were treated with
all-trans RA (0.1 mM) with or without the anti-HB-EGF (4 mg ml1) for 10 days.
The total hyaluronan concentration was measured using the ELSA assay.
(a) The results are expressed as percentage of the untreated control cultures
(means7range of two cultures). (b) For histology, organotypic cultures were
embedded in paraffin and stained with hematoxylin and eosin. Bar¼ 40 mm.
www.jidonline.org 801
SM Pasonen-Seppa¨nen et al.
All-trans RA Regulates Epidermal Hyaluronan
Varani et al., 2001) and EGFR activation (Kimura et al., 2005;
Rittie et al., 2006). Our data confirm and indicate that the
stimulation of hyaluronan synthesis by all-trans RA is also
dependent on this signaling mechanism. The hyaluronan
synthesis induced by all-trans RA was blocked by GM6001,
effective against MMP-1, -2, -3, and -9 (Santiskulvong and
Rozengurt, 2003), proteinases that may release and activate
the EGFR ligands. In addition to MMPs, the disintegrin and
metalloprotease family (ADAM 9, 10, 12, and 17) have been
reported to activate pro-HB-EGF (Roelle et al., 2003; Nanba
and Higashiyama, 2004; Blobel, 2005). However, it is not
known which protease is responsible for HB-EGF activation
after all-trans RA exposure at the moment. Since all-trans RA
also enhanced HB-EGF mRNA expression in mouse epider-
mis (data not shown) and in organotypic REK cultures, HB-
EGF seems to be the most probable ligand for the activation
of EGFR found after all-trans RA treatment, as suggested
previously (Kimura et al., 2005). Our data with the
neutralizing HB-EGF antibody support the hypothesis that
HB-EGF partly mediates the effects of all-trans RA on
epidermal keratinocytes. The fact that both the inhibitor of
EGFR and an inhibitor of MEK, one of the downstream
mediators, prevented or reduced epidermal hyperplasia and
hyaluronan synthesis also fit to the idea of EGFR signaling
involvement in all-trans RA responses in keratinocytes.
However, HB-EGF may not be the only signaling molecule
involved in all-trans RA-induced proliferation, which also
occurs in the epidermis of RARg/ mice epidermis without
HB-EGF elevation (Chapellier et al., 2002). It was recently
reported that in addition to HB-EGF, amphiregulin
contributes to the all-trans RA-induced hyperplasia (Rittie
et al., 2006).
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with or without the inhibitors for (a) 30 minutes, (b) 2 hours (EGF 20 ng ml1 served as positive control), and (c) 4 hours. In (d), organotypic REK cultures
were treated with cycloheximide (10 mg ml1) and all-trans RA with or without AG1478 for 4 hours. Cell lysates were analyzed by western blotting with
antibodies for the signaling proteins as indicated in the panels. The molecular mass of each band (in kDa) is shown at the left-hand side.
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Increased epidermal hyaluronan synthesis in all-trans RA-
treated organotypic cultures was associated with disturbed
epidermal differentiation characterized by diminished keratin
10 expression and profilaggrin maturation. These results with
organotypic REK cultures are in line with the previous
results from human and mouse skin epidermis (Fuchs
and Green, 1981; Fleckman et al., 1985; Eichner et al.,
1996). Interestingly, the all-trans RA-induced changes in
epidermal differentiation were not reversed by the inhibitors
of MMPs, EGFR, or MEK. This suggests that the effects of all-
trans RA on keratinocyte differentiation were mediated
through a mechanism different from that of hyaluronan
synthesis or proliferation, like through repressive action
of the nuclear receptor and coactivators on the keratin
promoter (Jho et al., 2005). Or alternatively, ligand-activated
nuclear receptors may suppress the expression of differen-
tiation markers by binding and inactivating AP1 (Presland
et al., 2001).
Recently, it was shown in breast cancer cells that estradiol
is able to stimulate membrane-bound G proteins, which leads
to the activation of MMPs and the liberation of HB-EGF, as
well as EGFR transactivation (Razandi et al., 2003). In
neuronal cells, all-trans RA induces rapid ERK activation,
proposed to be mediated through all-trans RA’s binding to
cytoplasmic RARs, which activate ERK by direct interaction
with upstream components of this signaling pathway
(Canon et al., 2004). In the REK cells, all-trans RA may also
directly activate EGFR in a manner independent of EGFR
ligands, similar to the activation resulting from UV light
(Peus et al., 1999).
The involvement of the EGFR pathway in all-trans RA
signaling was further demonstrated by the increased phos-
phorylation of EGFR and its downstream signaling molecule
ERK1/2. The fact that the action of all-trans RA on ERK1/2
activation was reversed with the EGFR inhibitor AG1478
strongly suggests that all-trans RA activates EGFR. ERK1/2
activation has been documented after all-trans RA treatment
in many cell types (Yen et al., 1999; Crowe et al., 2003;
Canon et al., 2004) including human skin epidermis in vivo
(Rittie et al., 2006). However, it is noteworthy that in
organotypic REK cultures, EGFR and ERK1/2 were already
activated after a 30-minute stimulation by all-trans RA,
suggesting that it triggered this MAPK-signaling pathway
directly, that is without binding to its nuclear receptors and
de novo protein synthesis. Indeed, studies on REKs with the
protein synthesis inhibitor cycloheximide showed that the
activation of ERK1/2 after a 4-hour all-trans RA treatment
does not require de novo protein synthesis. This confirms the
idea that the activation of this signaling pathway is a primary
response to all-trans RA (Figure 7).
CD44 immunostaining was increased in all-trans RA-
treated cultures despite the minor elevation of CD44 mRNA,
perhaps due to decreased protein turnover or translational
regulation. CD44 is the main hyaluronan binding receptor in
epidermal keratinocytes, and with hyaluronan it participates
in many vital cellular functions such as migration, adhesion,
proliferation, and differentiation. It has been reported that
CD44/ mouse keratinocytes do not respond to retinalde-
hyde (Calikoglu et al., 2006) or trauma-induced proliferation
(Kaya et al., 1997), suggesting that CD44 is essential in
All-trans RA AG1478
UO126
ERK1/2
Upregulation of genes involved
in hyaluronan synthesis and
epidermal hyperplasia
(e.g. Has2, Has3, HB-EGF, CD44)
EGFR pro HB-EGF
MEK
MMP
RXR RAR
GM6001
Figure 7. Schematic presentation of the alternatives for all-trans RA-induced
signaling leading to epidermal hyperplasia and enhanced hyaluronan
production in organotypic REK cultures. All-trans RA can regulate the
expression of genes either via nuclear receptors (RXR-RAR) or via a rapid
nongenomic mechanism involving, for example, EGFR-ERK activation.
All-trans RA possibly activates EGFR via HB-EGF and/or through other
cytoplasmic or membrane-associated mechanisms. This causes ERK1/2
activation and downstream activation of transcription factors (e.g. STAT3),
which regulate the expression of genes involved in epidermal hyperplasia and
hyaluronan synthesis. Has2 is also regulated via nuclear receptors, since it has
a functional RARE in its promoter.
215
42
57
Profilaggrin
Filaggrin
Keratin 10
RA _   _ +   + +   ++   ++   +
Control AG1478 UO126 GM6001c
a b
Figure 6. The expression of epidermal differentiation markers.
(a, b) Two-week-old organotypic cultures were subjected to (b) all-trans RA
for 10 days, and stained for keratin 10 as described in Materials and
Methods. (a) Control cultures express keratin 10 in suprabasal cells, while its
expression is strongly diminished by (b) all-trans RA. (c) Keratinocyte
differentiation was estimated with filaggrin and keratin 10 antibodies in
western blotting. The bands at 215 and 42 kDa show profilaggrin and mature
filaggrin, respectively. The figure represents one of two separate experiments
with equivalent results. Bar¼ 30mm.
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keratinocyte growth stimulation. Together, enhanced expres-
sions of CD44 and hyaluronan may further increase the
hyperplastic effect of all-trans RA in organotypic keratinocyte
cultures. Elevated CD44 expression may also contribute to
MMP and growth factor complex assembly in the plasma
membrane (Yu et al., 2001), promoting HB-EGF signaling
after all-trans RA treatment.
In summary, the results provide new insights in to all-trans
RA-induced signaling in epidermal keratinocytes. On the one
hand, all-trans RA regulates the expression of genes involved
in proliferation (Fisher and Voorhees, 1996), differentiation
(Presland et al., 2001), and hyaluronan synthesis (Saavalainen
et al., 2005) by the conventional mechanism involving RXR/
RAR heterodimers binding to RAREs. On the other hand, all-
trans RA causes EGFR and ERK1/2 activation without
involvement of RAREs, through ERK activation of transcrip-
tion factors such as STAT3. This MAPK-signaling cascade
contributes to the expression of Has2 and HB-EGF, hyal-
uronan synthesis, and the protein level of CD44, in addition
to causing the epidermal hyperplasia reported earlier.
MATERIALS AND METHODS
Reagents
All-trans RA and cycloheximide were obtained from Sigma (St Louis,
MO) and the EGF-receptor inhibitor AG1478 from LC Laboratoriess
(Woburn, MA). The MMP inhibitor GM6001 and the MEK-kinase
inhibitor UO126 were purchased from Calbiochem (La Jolla, CA).
The neutralizing anti-human HB-EGF antibody (AF-259-NA) was
obtained from R&D Systems (Minneapolis, MN). All-trans RA and
the inhibitors were dissolved in sterile filtered DMSO, protected
from light, and stored frozen. All-trans RA and the inhibitor stocks
were diluted in culture medium at the time of use. All-trans RA was
used at 0.1 mM, AG1478 at 0.1 mM, GM6001 at 1–10 mM, UO126 at
1–10 mM, and anti-HB-EGF at 4 mg ml1 final concentrations in
complete medium.
Cell culture
A keratinocyte cell line derived from the newborn rat skin (REK) was
used (Baden and Kubilus, 1983). The stock cultures were grown in
minimum essential medium (Life Technologies Ltd, Paisley, Scot-
land) with 10% fetal bovine serum (HyClone, Logan, UT), 4 mM
L-glutamine (Sigma), and 50 mg ml1 streptomycin sulfate and
50 U ml1 penicillin (Sigma). REKs were passaged twice a week at
a 1:5 split ratio using 0.05% trypsin (w/v) and 0.02% EDTA (w/v) in
phosphate-buffered saline (PBS).
For the experiments on monolayer cultures, 100,000 cells were
seeded on six-well plates, grown to near confluency, and the test
substances added in fresh medium. After 24 hours, the culture media
were collected for hyaluronan assay.
For organotypic cultures, REKs were grown at the air–liquid
interface on type I collagen support (Becton Dickinson Labware,
Bedford, MA) as described (Pasonen-Seppa¨nen et al., 2001). The
culture medium was supplemented with all-trans RA with or without
the inhibitors from the day after the cultures were raised to the
air–liquid interface (¼ 4th day from cell plating). The cultures were
grown for 2 weeks, with the medium changed daily for the first week
and every 2 days thereafter. The cultures were treated with the
test substances for 10 days before analyses (histologic, metabolic
labeling, hyaluronan ELSA, differentiation assays). Alternatively,
2-week-old cultures were treated with the test substances for
1–12 hours for RT-PCR and protein phosphorylation studies.
Morphometry
Hematoxylin- and eosin-stained sections were systematically
sampled by taking six digital images with CoolSNAP camera
(Roper Scientific, Trenton, NJ) from each culture at constant intervals
using a  20 objective. The height of the vital epidermis was
measured from each digital image at constant intervals using
the ImageJ software. Data from 5–6 cultures were analyzed for
each group.
Immunohistochemical demonstration of CD44 and keratin 10 in
organotypic cultures
The organotypic cultures were fixed in Histochoices (Amresco,
Solon, OH) overnight and embedded in paraffin. CD44 and keratin
10 were visualized as described previously (Pasonen-Seppa¨nen
et al., 2003) using anti-rat monoclonal CD44 antibody (OX50, 1:50
dilution, Biosource, Camarillo, CA) and a monoclonal keratin 10
antibody (1:10 dilution, Monosan, Uden, the Netherlands).
Histochemical demonstration of hyaluronan
Hyaluronan staining was carried out on sections from paraformal-
dehyde-fixed (2%) and glutaraldehyde-fixed (0.5%) organotypic
culture specimens with a specific probe, biotinylated hyaluronan
binding complex (HABC), purified from bovine articular cartilage as
described previously (Tammi et al., 1994). The sections were treated
with 1% H2O2 to block endogenous peroxidases, and stained for
hyaluronan using biotinylated HABC, avidin–biotin–peroxidase
complex (Vector Laboratories Inc., Burlingame, CA), and diamino-
benzidine (DAB) (Sigma), as described (Karvinen et al., 2003). The
specificity of the staining was controlled by preincubating the
sections with Streptomyces hyaluronidase (100 turbidity reducing
units per ml, 3 hours at 371C) to remove hyaluronan from the tissue
(Tammi et al., 1989).
Hyaluronan assay
The collagen and the epidermis were separated with fine tweezers.
Hyaluronan content was measured from three different compart-
ments of the organotypic keratinocyte cultures (medium, collagen
gel, and epidermis) and from monolayer REK medium, using an ELSA
as described (Pasonen-Seppa¨nen et al., 2003). The medium was
changed 24 hours before the assay. Briefly, the organotypic tissue
samples were extracted with acetone, weighed and digested with
papain (400 mg ml1) at 601C overnight. After digestion, each
medium (1.5 ml) was heated at 1001C for 5 minutes and the digests
were diluted with 1% BSA in PBS before the assay.
Ninety-six-well Maxisorp plates (Nunc, Roskilde, Denmark) were
coated with HABC (1 mg ml1) overnight at 41C, washed with 0.5%
Tween-PBS, and blocked with 1% BSA. The dilutions of standard
hyaluronan (Provisc, Algon Laboratories, Fort Worth, TX) and the
samples were aliquoted to the wells. After 1-hour incubation at
371C, the plates were washed with Tween-PBS and incubated with
1mg ml1 biotinylated HABC for 1 hour. The biotinylated HABC
bound to hyaluronan was visualized using a horseradish peroxida-
se–streptavidin complex (1:20,000, Vector Laboratories Inc.)
and 0.5% 3,30,5,50-tetramethylbenzidine (Sigma) in 0.1 M sodium
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acetate, pH 6.0, 0.005% H2O2. The absorbances were read at
450 nm after stopping the reaction with 2 M H2SO4. Each sample and
standard were performed in triplicate.
Metabolic labeling of the organotypic cultures
Ten days after the cultures were raised to the air–liquid interface, the
cultures were metabolically labeled with 20 mCi ml1 of [3H]gluco-
samine and 100mCi ml1 of 35SO4 (both isotopes from Amersham,
Little Chalfont, UK) for 24 hours. At the end of the labeling, the
medium (1.5 ml) was collected and the culture insert was washed
once with 0.5 ml of PBS, which was added to the medium
compartment. Thereafter, the collagen and the epidermis were
separated with fine tweezers. The three ‘‘compartments’’ of the
cultures (medium, collagen gel, and epidermis) were analyzed
separately. Results from medium and collagen gel were combined
and expressed as a single value.
Purification of the radiolabeled hyaluronan and
glycosaminoglycans
The glycosaminoglycans were purified as described (Tammi et al.,
1998) using cetyl pyridinium chloride and ethanol precipitations.
After digestion with chondroitinase ABC and Streptococcal hyalur-
onidase (both from Seikagaku Kogyo, Tokyo, Japan), the specific
disaccharides were analyzed using a Superdex Peptide column
(Amersham Biosciences, Little Chalfont, UK). The chemical quanti-
tation of hyaluronan and other glycosaminoglycans was performed
as described in Tammi et al. (2000).
Molecular mass distribution of hyaluronan
To estimate the molecular mass of secreted hyaluronan (medium,
collagen matrix), organotypic REK cultures were incubated for
24 hours with all-trans RA (0.1 mM) with or without AG1478 (0.1 mM),
and 20 mCi ml1 of [3H]glucosamine. The radiolabeled samples were
chromatographed on a 1 30 cm column of Sephacryl S-1000
(Amersham Biosciences), equilibrated and eluted at 0.4 ml minute1
with 0.15 M sodium acetate and 0.1% CHAPS (Sigma), pH 6.8. Two
aliquots were taken from each fraction. One aliquot was incubated
with 12.5 mU of Streptomyces hyaluronidase overnight at 371C,
whereas the other in buffer only. Both aliquots were precipitated in
1% cetyl pyridinium chloride with 5mg of carrier hyaluronan. The
size distribution of hyaluronan in the samples was estimated as
described (Tammi et al., 1991).
Quantitative real-time RT-PCR
Total RNA was isolated from organotypic cultures with Eurozols
(Euroclone Ltd, UK) according to the manufacturer’s instructions. For
quantitative RT-PCR, the mRNA samples were treated with TURBO
DNA-freeTM DNase (Ambion, Austin, TX), quantitated with a
spectrophotometer, and equal amounts of RNA were taken for the
reverse transcriptase reaction. Real-time PCR was performed in an
MX3000P thermal cycler (Stratagene, La Jolla, CA), and cDNA
samples were analyzed with AbsoluteTM MAX 2-step quantitative
RT-PCR SYBRs Green kit (ABgene, Epsom Surrey, UK). Table 1
(Supplementary Data 2) shows the specific primers for quantitative
RT-PCR. Fold inductions were calculated using the formula
2(DDCt), where DDCt is the DCt (treatment)DCt (control). DCt is
Ct Target geneCt Arpo (acidic ribosomal phosphoprotein, used to
normalize transcript levels between samples), and Ct is the cycle
in which the detection threshold is crossed. In semi-quantitative
RT-PCR, the GeneAmp RNA PCR Reagent Kit (Applied Biosystems,
Foster City, CA) was used.
Western blots
The organotypic REK cultures (epidermis after removing the collagen
matrix) were homogenized in 8 M urea, 50 mM Tris, pH 7.6, 100 mM
dithiothreitol, 0.13 M 2-mercaptoethanol, 100mg ml1 phenyl-
methylsulfonyl fluoride, 20 mg ml1 sodium orthovanadate and
100mg ml1 aprotinin with Ultra Turrax (Ystral, Germany), and
centrifuged at 13,000 g for 15 minutes. The supernatant was used for
the determination of protein concentration (Bradford and Richards,
1976) and Western blotting. In EGFR western blotting, the following
RIPA-lysis buffer was used: PBS, pH 7.4, with 1% Nonidet P-40,
0.5% sodium deoxycholate, 0.1% SDS, 100mg ml1 phenylmethyl-
sulfonyl fluoride, 10 mg ml1 sodium orthovanadate, and
100mg ml1 aprotinin.
Protein samples (15–20 mg) were resolved by 10% SDS-PAGE,
followed by transfer onto ImmobilonTM-NC membranes (Millipore,
Bedford, MA) or PVDF western blotting membranes (Roche
Diagnostics GmbH, Mannheim, Germany) by 35 mA cm2 constant
current with a SammyTM semidry blotter (Schleicher and Schuell,
Dassel, Germany). The blots were blocked for 40 minutes at room
temperature in 10 mM Tris, 150 mM NaCl, pH 7.4 (Tris-saline
blocking buffer) containing 1–5% fat-free milk powder and
0.1–0.3% Tween-20. They were then incubated with the primary
antibody overnight at þ 41C, using the following antibody dilutions:
anti-filaggrin 1:9,000 (a gift from Dr Beverly Dale-Crunk); anti-
keratin 10 1:100 (Monosan); anti-pEGFR[pY1068] 1:300 (BioSource);
anti-pERK1/2 1:500 (Santa Cruz, Santa Cruz, CA); anti-ERK2
1:2,000 (Santa Cruz); anti-pSTAT3 1:250 (Santa Cruz); anti-pJNK
1:200 (Santa Cruz); anti-p-cJUN 1:200 (Santa Cruz); anti-pPI3K
1:250 (Santa Cruz); anti-pELK 1:500 (Santa Cruz); and anti-actin
1:3,000 (Sigma). After washing with 0.1–0.5% Tween-20 in
Tris-saline buffer, the blots were incubated with the horse-
radish peroxidase-conjugated secondary antibody for 1 hour,
using the following dilutions: anti-rabbit IgG 1:20,000 (Zymed
Laboratories, San Francisco, CA) and anti-mouse IgG
1:5,000–1:20,000 (Santa Cruz). The protein bands were visualized
using the NENTM chemiluminescent detection system (Life Science
Products, Boston, MA) and Kodak Biomax Light Film (Eastman
Kodak Company, NY).
Statistical analysis
One-way analysis of variance with Tukey’s post hoc test was used to
analyze the data from morphometric measurements (epidermal
thickness), hyaluronan ELSA, and RT-PCR. A difference was
considered statistically significant when the P-value was less
than 0.05.
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